FINANCIAL HIGHLIGHTS FROM THIS 3 YEAR FILING PERIOD INCLUDE:
-There has not been any new convertible debt financing since 2013
The business is currently self-funding all daily operations
Business expansion into the healthcare market grew 2014 annual revenue to over $4,000,000
-The Company sustained annual revenue over $3.3 million in 2015
-Market wide changes in healthcare trimmed 2016 annual revenue to $630,000
-The Company reinvested previous years' profits into new product development, acquisitions, new businesses developments, personnel training and healthcare technologies to name a few of many more items.
-As of March 31, 2017, Dewmar International has $3.8 million is assets on its Balance Sheet, not including its market cap
Market Data 
Markets 
AI
